UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 174 filers reported holding UNIQURE NV in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,070,000 | -19.2% | 500,000 | -9.1% | 2.03% | -22.5% |
| Q4 2022 | $12,468,500 | +53.5% | 550,000 | +27.0% | 2.62% | +65.8% |
| Q3 2022 | $8,123,000 | +23.4% | 433,000 | +22.6% | 1.58% | +16.5% |
| Q2 2022 | $6,582,000 | +114.3% | 353,106 | +107.7% | 1.35% | +69.5% |
| Q1 2022 | $3,072,000 | +48.1% | 170,000 | +70.0% | 0.80% | +39.2% |
| Q4 2021 | $2,074,000 | -47.4% | 100,000 | +81.8% | 0.57% | -62.6% |
| Q4 2019 | $3,941,000 | – | 55,000 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |